Shanghai Pharma Latest To Investigate Allegations Of Bribery In China
This article was originally published in PharmAsia News
Executive Summary
China’s second-largest pharmaceutical distributor Shanghai Pharmaceuticals is investigating allegations in a local paper that its subsidiary Qingdao Growful Pharmaceutical paid $126,200 in bribes between January and June to staff at 31 hospitals.